2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.

[1]  R. Hunter,et al.  Catheter Ablation of Atrial Fibrillation in Patients With Left Ventricular Systolic Dysfunction: A Systematic Review and Meta-Analysis , 2014, Circulation. Arrhythmia and electrophysiology.

[2]  T. Wadden,et al.  Reprint: 2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk. , 2014, Journal of the American Pharmacists Association : JAPhA.

[3]  Robert F Kushner,et al.  2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. , 2014, Journal of the American College of Cardiology.

[4]  Jennifer G. Robinson,et al.  2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2014, Circulation.

[5]  Thoralf M Sundt,et al.  2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Journal of the American College of Cardiology.

[6]  Talicia Tarver,et al.  HEART DISEASE AND STROKE STATISTICS–2014 UPDATE: A REPORT FROM THE AMERICAN HEART ASSOCIATION , 2014 .

[7]  K. Lunetta,et al.  Novel genetic markers associate with atrial fibrillation risk in Europeans and Japanese. , 2014, Journal of the American College of Cardiology.

[8]  N. Wong.  Faculty Opinions recommendation of 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014 .

[9]  Lluís Mont,et al.  Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study) , 2013, European heart journal.

[10]  J. Hirsh,et al.  Betrixaban (PRT054021): pharmacology, dose selection and clinical studies. , 2014, Future cardiology.

[11]  D. Fernández de Velasco Pérez.  [Dabigatran versus warfarin in patients with mechanical heart valves]. , 2014, Revista clinica espanola.

[12]  Rahul Wadke,et al.  Atrial fibrillation. , 2022, Disease-a-month : DM.

[13]  E. Antman,et al.  Edoxaban versus warfarin in patients with atrial fibrillation. , 2013, The New England journal of medicine.

[14]  G. Hindricks,et al.  Novel oral anticoagulants in a real-world cohort of patients undergoing catheter ablation of atrial fibrillation. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[15]  S. Mittal,et al.  Ganglionated plexus ablation vs linear ablation in patients undergoing pulmonary vein isolation for persistent/long-standing persistent atrial fibrillation: a randomized comparison. , 2013, Heart rhythm.

[16]  H. May,et al.  Atrial fibrillation ablation patients have long-term stroke rates similar to patients without atrial fibrillation regardless of CHADS2 score. , 2013, Heart rhythm.

[17]  Petr Neuzil,et al.  Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology). , 2013, Journal of the American College of Cardiology.

[18]  David O. Martin,et al.  Use of Dabigatran for Periprocedural Anticoagulation in Patients Undergoing Catheter Ablation for Atrial Fibrillation , 2013, Circulation. Arrhythmia and electrophysiology.

[19]  Atul Verma,et al.  Pacemaker or defibrillator surgery without interruption of anticoagulation. , 2013, The New England journal of medicine.

[20]  R. Charnigo,et al.  Increased mortality among patients taking digoxin--analysis from the AFFIRM study. , 2013, European heart journal.

[21]  J. Cleland,et al.  Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial. , 2013, European heart journal.

[22]  Tom Wong,et al.  A randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure. , 2013, Journal of the American College of Cardiology.

[23]  W. Shen,et al.  Effect of pacing method on risk of sudden death after atrioventricular node ablation and pacemaker implantation in patients with atrial fibrillation. , 2013, Heart rhythm.

[24]  A. Camm,et al.  European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[25]  Anne B Curtis,et al.  Biventricular pacing for atrioventricular block and systolic dysfunction. , 2013, The New England journal of medicine.

[26]  J. Ruskin,et al.  Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial. , 2013, Journal of the American College of Cardiology.

[27]  Marsha E Reichman,et al.  Dabigatran and postmarketing reports of bleeding. , 2013, The New England journal of medicine.

[28]  F. Morady,et al.  Dabigatran vs warfarin for radiofrequency catheter ablation of atrial fibrillation. , 2013, Heart rhythm.

[29]  P. Neužil,et al.  Percutaneous Left Atrial Appendage Closure for Stroke Prophylaxis in Patients With Atrial Fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients With Atrial Fibrillation) Trial , 2013, Circulation.

[30]  D. Ferrante,et al.  Omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: results of the FORWARD (Randomized Trial to Assess Efficacy of PUFA for the Maintenance of Sinus Rhythm in Persistent Atrial Fibrillation) trial. , 2013, Journal of the American College of Cardiology.

[31]  C. Morillo,et al.  Discerning the incidence of symptomatic and asymptomatic episodes of atrial fibrillation before and after catheter ablation (DISCERN AF): a prospective, multicenter study. , 2013, JAMA internal medicine.

[32]  F. Marchlinski,et al.  Time to recurrence of atrial fibrillation influences outcome following catheter ablation. , 2013, Heart rhythm.

[33]  Jun Zhu,et al.  Efficacy and Safety of Apixaban in Patients Following Cardioversion for Atrial Fibrillation: Insights from the ARISTOTLE trial , 2013 .

[34]  Deepak L. Bhatt,et al.  2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Circulation.

[35]  Biykem Bozkurt,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.

[36]  Gregory Y H Lip,et al.  New oral anticoagulants for stroke prevention in atrial fibrillation: impact of gender, heart failure, diabetes mellitus and paroxysmal atrial fibrillation , 2012, Expert review of cardiovascular therapy.

[37]  K. Furie,et al.  Oral antithrombotic agents for the prevention of stroke in nonvalvular atrial fibrillation: a science advisory for healthcare professionals from the American Heart Association/American Stroke Association. , 2012, Stroke.

[38]  D. Mozaffarian,et al.  Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial. , 2012, JAMA.

[39]  G. Breithardt,et al.  Abstract 19281: Outcomes Following Cardioversion and Atrial Fibrillation Ablation in Patients Treated with Rivaroxaban and Warfarin in the ROCKET AF Trial , 2012 .

[40]  Gerhard Hindricks,et al.  2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[41]  Sean M. O'Brien,et al.  Surgical ablation of atrial fibrillation trends and outcomes in North America. , 2012, The Journal of thoracic and cardiovascular surgery.

[42]  D. Singer,et al.  Detection of previously undiagnosed atrial fibrillation in patients with stroke risk factors and usefulness of continuous monitoring in primary stroke prevention. , 2012, The American journal of cardiology.

[43]  M. Keltai,et al.  Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial. , 2012, European heart journal.

[44]  E. Benjamin,et al.  Outcomes of Medicare Beneficiaries Undergoing Catheter Ablation for Atrial Fibrillation , 2012, Circulation.

[45]  M. Rienstra,et al.  An Update on the Prognosis of Patients With Atrial Fibrillation , 2012, Circulation.

[46]  S. Connolly,et al.  Radiofrequency Ablation vs Antiarrhythmic Drugs as First-Lne Treatment of Symptomatic Atrial Fibrillation: (RAAFT 2): a Randomized Trial , 2012 .

[47]  Sanjiv M Narayan,et al.  Focal impulse and rotor modulation ablation of sustaining rotors abruptly terminates persistent atrial fibrillation to sinus rhythm with elimination on follow-up: a video case study. , 2012, Heart rhythm.

[48]  Wouter-Jan Rappel,et al.  Treatment of atrial fibrillation by the ablation of localized sources: CONFIRM (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation) trial. , 2012, Journal of the American College of Cardiology.

[49]  W. Hiatt,et al.  Proarrhythmic Potential of Dronedarone: Emerging Evidence from Spontaneous Adverse Event Reporting , 2012, Pharmacotherapy.

[50]  S. Nattel,et al.  The multidimensional role of calcium in atrial fibrillation pathophysiology: mechanistic insights and therapeutic opportunities. , 2012, European heart journal.

[51]  G. Hindricks,et al.  ESC-EURObservational Research Programme: the Atrial Fibrillation Ablation Pilot Study, conducted by the European Heart Rhythm Association. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[52]  G. Breithardt,et al.  Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial , 2012, The Lancet.

[53]  S. Connolly,et al.  A comparison of dabigatran etexilate with warfarin in patients with mechanical heart valves: THE Randomized, phase II study to evaluate the safety and pharmacokinetics of oral dabigatran etexilate in patients after heart valve replacement (RE-ALIGN). , 2012, American heart journal.

[54]  D. Lake,et al.  Impact of the CHA2DS2-VASc score on anticoagulation recommendations for atrial fibrillation. , 2012, The American journal of medicine.

[55]  M. Gold,et al.  Meta-Analysis of Bleeding Complications Associated With Cardiac Rhythm Device Implantation , 2012, Circulation. Arrhythmia and electrophysiology.

[56]  G. Lip,et al.  Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study , 2012, BMJ : British Medical Journal.

[57]  P. Almgren,et al.  Genetic polymorphisms for estimating risk of atrial fibrillation in the general population: a prospective study. , 2012, Archives of internal medicine.

[58]  J. McMurray,et al.  Eplerenone and atrial fibrillation in mild systolic heart failure: results from the EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure) study. , 2012, Journal of the American College of Cardiology.

[59]  W. Rappel,et al.  Clinical Mapping Approach To Diagnose Electrical Rotors and Focal Impulse Sources for Human Atrial Fibrillation , 2012, Journal of cardiovascular electrophysiology.

[60]  K. Lunetta,et al.  Meta-analysis identifies six new susceptibility loci for atrial fibrillation , 2012, Nature Genetics.

[61]  V. Menon,et al.  Current trial-associated outcomes with warfarin in prevention of stroke in patients with nonvalvular atrial fibrillation: a meta-analysis. , 2012, Archives of internal medicine.

[62]  Dhanunjaya R. Lakkireddy,et al.  Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry. , 2012, Journal of the American College of Cardiology.

[63]  R. Falk.  Dronedarone in high-risk permanent atrial fibrillation. , 2012, The New England journal of medicine.

[64]  Adrian V. Hernández,et al.  Dabigatran association with higher risk of acute coronary events: meta-analysis of noninferiority randomized controlled trials. , 2012, Archives of internal medicine.

[65]  Stanley Nattel,et al.  Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control. , 2012, The Canadian journal of cardiology.

[66]  R. Winkle,et al.  The Use of Dabigatran Immediately After Atrial Fibrillation Ablation , 2012, Journal of cardiovascular electrophysiology.

[67]  Ashok J. Shah,et al.  Teaching Rounds in Cardiac Electrophysiology How to Approach Reentrant Atrial Tachycardia After Atrial Fibrillation Ablation , 2012 .

[68]  J. Hirsh,et al.  Antiplatelet drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[69]  D. Singer,et al.  Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[70]  G. Breithardt,et al.  Angiotensin II-Antagonist in Paroxysmal Atrial Fibrillation (ANTIPAF)-Trial Running title: Goette et al.; The ANTIPAF Trial , 2010 .

[71]  A. Capucci,et al.  Subclinical atrial fibrillation and the risk of stroke. , 2012, The New England journal of medicine.

[72]  Paul J. Wang,et al.  Procedural complications, rehospitalizations, and repeat procedures after catheter ablation for atrial fibrillation. , 2012, Journal of the American College of Cardiology.

[73]  J. Brugada,et al.  Atrial Fibrillation Catheter Ablation Versus Surgical Ablation Treatment (FAST): A 2-Center Randomized Clinical Trial , 2012, Circulation.

[74]  S. Hariharan,et al.  Clinical Pharmacology Basis of Deriving Dosing Recommendations for Dabigatran in Patients With Severe Renal Impairment , 2012, Journal of clinical pharmacology.

[75]  Nassir Marrouche,et al.  Atrial Fibrosis Quantified Using Late Gadolinium Enhancement MRI is Associated With Sinus Node Dysfunction Requiring Pacemaker Implant , 2012, Journal of cardiovascular electrophysiology.

[76]  S. Sack,et al.  Detection of atrial high-rate events by continuous Home Monitoring: clinical significance in the heart failure–cardiac resynchronization therapy population , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[77]  M. Fishbein,et al.  Neural mechanisms of atrial fibrillation , 2006 .

[78]  池田 達則.  Augmented single-unit muscle sympathetic nerve activity in heart failure with chronic atrial fibrillation , 2012 .

[79]  M. Fishbein,et al.  Neural mechanisms of atrial arrhythmias , 2012, Nature Reviews Cardiology.

[80]  G. Wassmer,et al.  Preoperative statin therapy for patients undergoing cardiac surgery. , 2012, The Cochrane database of systematic reviews.

[81]  Laura Mauri,et al.  2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. , 2011, Circulation.

[82]  Paul J. Pearson,et al.  Left atrial appendage occlusion: lessons learned from surgical and transcatheter experiences. , 2011, The Annals of thoracic surgery.

[83]  Ashok J. Shah,et al.  Localized reentry within the left atrial appendage: arrhythmogenic role in patients undergoing ablation of persistent atrial fibrillation. , 2011, Heart rhythm.

[84]  A. Mills,et al.  Is discharge to home after emergency department cardioversion safe for the treatment of recent-onset atrial fibrillation? , 2011, Annals of emergency medicine.

[85]  Hugh Calkins,et al.  Complications arising from catheter ablation of atrial fibrillation: temporal trends and predictors. , 2011, Heart rhythm.

[86]  John Spertus,et al.  AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. , 2011, Circulation.

[87]  Y. Adler,et al.  Colchicine Reduces Postoperative Atrial Fibrillation: Results of the Colchicine for the Prevention of the Postpericardiotomy Syndrome (COPPS) Atrial Fibrillation Substudy , 2011, Circulation.

[88]  Salim Yusuf,et al.  Risks for Stroke, Bleeding, and Death in Patients With Atrial Fibrillation Receiving Dabigatran or Warfarin in Relation to the CHADS2 Score: A Subgroup Analysis of the RE-LY Trial , 2011, Annals of Internal Medicine.

[89]  S. Redline,et al.  Role of obstructive sleep apnea in cardiovascular disease , 2011, Current opinion in cardiology.

[90]  R. Asinger,et al.  Warfarin in atrial fibrillation patients with moderate chronic kidney disease. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[91]  M. Brignole,et al.  Cardiac resynchronization therapy in patients undergoing atrioventricular junction ablation for permanent atrial fibrillation: a randomized trial. , 2011, European heart journal.

[92]  C. Polanczyk,et al.  Very Low Risk of Thromboembolic Events in Patients Undergoing Successful Catheter Ablation of Atrial Fibrillation With a CHADS2 Score ⩽3: A Long-Term Outcome Study , 2011, Circulation. Arrhythmia and electrophysiology.

[93]  D. Packer,et al.  Success of Ablation for Atrial Fibrillation in Isolated Left Ventricular Diastolic Dysfunction: A Comparison to Systolic Dysfunction and Normal Ventricular Function , 2011, Circulation. Arrhythmia and electrophysiology.

[94]  D. Atar,et al.  Apixaban versus warfarin in patients with atrial fibrillation. , 2011, The New England journal of medicine.

[95]  M. Nebojša,et al.  Lethal Outcome After Intravenous Administration of Amiodarone in Patient with Atrial Fibrillation and Ventricular Preexcitation , 2011, Journal of cardiovascular electrophysiology.

[96]  Michel Haïssaguerre,et al.  Incidence of asymptomatic intracranial embolic events after pulmonary vein isolation: comparison of different atrial fibrillation ablation technologies in a multicenter study. , 2011, Journal of the American College of Cardiology.

[97]  Niels Voigt,et al.  Recent advances in the molecular pathophysiology of atrial fibrillation. , 2011, The Journal of clinical investigation.

[98]  E. Aliot,et al.  Rationale and current perspective for early rhythm control therapy in atrial fibrillation , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[99]  D. Singer,et al.  A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study. , 2011, Journal of the American College of Cardiology.

[100]  W. Ghali,et al.  Outcomes of cardiac resynchronization therapy in patients with versus those without atrial fibrillation: a systematic review and meta-analysis. , 2011, Heart rhythm.

[101]  G. Wells,et al.  Approach to the Catheter Ablation Technique of Paroxysmal and Persistent Atrial Fibrillation: A Meta‐Analysis of the Randomized Controlled Trials , 2011, Journal of cardiovascular electrophysiology.

[102]  P. Loewen,et al.  Risk of bleeding with oral anticoagulants: an updated systematic review and performance analysis of clinical prediction rules , 2011, Annals of Hematology.

[103]  S. Yusuf,et al.  Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation: An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Trial , 2011, Circulation.

[104]  X. Jouven,et al.  Atrial Fibrillation and Death After Myocardial Infarction: A Community Study , 2011, Circulation.

[105]  K. Ylitalo,et al.  Catheter ablation of atrial fibrillation in patients with therapeutic oral anticoagulation treatment. , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[106]  O. Centurión.  Atrial Fibrillation in the Wolff-Parkinson-White Syndrome. , 2011, Journal of atrial fibrillation.

[107]  S. Johnston,et al.  Estimation of Total Incremental Health Care Costs in Patients With Atrial Fibrillation in the United States , 2011, Circulation. Cardiovascular quality and outcomes.

[108]  Sunil K. Agarwal,et al.  Absolute and Attributable Risks of Atrial Fibrillation in Relation to Optimal and Borderline Risk Factors: The Atherosclerosis Risk in Communities (ARIC) Study , 2011, Circulation.

[109]  M. Hardy,et al.  Multiplanar phalangeal and metatarsal osteotomies for hallux rigidus. , 2011, Clinics in podiatric medicine and surgery.

[110]  Bernhard Meier,et al.  Left atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation: initial European experience. , 2011, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[111]  M. Hirai,et al.  Randomized trial of angiotensin II-receptor blocker vs. dihydropiridine calcium channel blocker in the treatment of paroxysmal atrial fibrillation with hypertension (J-RHYTHM II study). , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[112]  H. Halperin,et al.  Continuation of warfarin during pacemaker or implantable cardioverter-defibrillator implantation: a randomized clinical trial. , 2011, Heart rhythm.

[113]  Kenneth A Ellenbogen,et al.  2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on Dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2011, Circulation.

[114]  A. Camm,et al.  Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention. , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[115]  Nick Freemantle,et al.  Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation. , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[116]  E. Kholmovski,et al.  Association of left atrial fibrosis detected by delayed-enhancement magnetic resonance imaging and the risk of stroke in patients with atrial fibrillation. , 2011, Journal of the American College of Cardiology.

[117]  Y. Ohashi,et al.  Alcohol consumption and risk of atrial fibrillation: a meta-analysis. , 2011, Journal of the American College of Cardiology.

[118]  G. Boriani,et al.  Device-detected atrial tachyarrhythmias predict adverse outcome in real-world patients with implantable biventricular defibrillators. , 2011, Journal of the American College of Cardiology.

[119]  E. Aliot,et al.  Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[120]  J. Kalman,et al.  Pulmonary Vein Antral Isolation for Paroxysmal Atrial Fibrillation: Results from Long‐Term Follow‐Up , 2010, Journal of cardiovascular electrophysiology.

[121]  S. Yusuf,et al.  Dabigatran Versus Warfarin in Patients With Atrial Fibrillation: An Analysis of Patients Undergoing Cardioversion , 2010, Circulation.

[122]  M. Gold.  Effect of Home Testing of International Normalized Ratio on Clinical Events , 2011 .

[123]  R. Troughton,et al.  Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. , 2011, The New England journal of medicine.

[124]  N. Coplan,et al.  Embolic risk in atrial fibrillation that arises from hyperthyroidism: review of the medical literature. , 2011, Texas Heart Institute journal.

[125]  R. Damiano,et al.  The Cox maze IV procedure: predictors of late recurrence. , 2011, The Journal of thoracic and cardiovascular surgery.

[126]  A. Camm,et al.  Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part II: secondary prevention. , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[127]  Kenneth A Ellenbogen,et al.  2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2011, Heart rhythm.

[128]  Zahi A Fayad,et al.  2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2010, Circulation.

[129]  Andreas Metzner,et al.  Long-Term Results of Catheter Ablation in Paroxysmal Atrial Fibrillation: Lessons From a 5-Year Follow-Up , 2010, Circulation.

[130]  S. Yusuf,et al.  Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial , 2010, The Lancet Neurology.

[131]  Michael J Pencina,et al.  Association between familial atrial fibrillation and risk of new-onset atrial fibrillation. , 2010, JAMA.

[132]  Kathleen F. Kerr,et al.  European Ancestry as a Risk Factor for Atrial Fibrillation in African Americans , 2010, Circulation.

[133]  Gregory Y H Lip,et al.  A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. , 2010, Chest.

[134]  W. Ghali,et al.  Meta-analysis of the effectiveness and safety of catheter ablation of atrial fibrillation in patients with versus without left ventricular systolic dysfunction. , 2010, The American journal of cardiology.

[135]  Carlo Boffano,et al.  Radiofrequency Catheter Ablation of Atrial Fibrillation: A Cause of Silent Thromboembolism?: Magnetic Resonance Imaging Assessment of Cerebral Thromboembolism in Patients Undergoing Ablation of Atrial Fibrillation , 2010, Circulation.

[136]  B. Lindsay,et al.  Noninvasive Characterization of Epicardial Activation in Humans With Diverse Atrial Fibrillation Patterns , 2010, Circulation.

[137]  D. Packer,et al.  Long‐Term Outcome of Atrial Fibrillation Ablation: Impact and Predictors of Very Late Recurrence , 2010, Journal of cardiovascular electrophysiology.

[138]  Jeroen J. Bax,et al.  Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[139]  D. Lin,et al.  Efficacy and Risk of Atrial Fibrillation Ablation Before 45 Years of Age , 2010, Circulation. Arrhythmia and electrophysiology.

[140]  Fredrik Folke,et al.  Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation. , 2010, Archives of internal medicine.

[141]  N. Nikolaou,et al.  Effect of high doses of magnesium on converting ibutilide to a safe and more effective agent. , 2010, The American journal of cardiology.

[142]  D. Lambrechts,et al.  The Association of the 4q25 Susceptibility Variant for Atrial Fibrillation With Stroke Is Limited to Stroke of Cardioembolic Etiology , 2010, Stroke.

[143]  G. Lip,et al.  Underuse of oral anticoagulants in atrial fibrillation: a systematic review. , 2010, The American journal of medicine.

[144]  Shien-Fong Lin,et al.  Intrinsic Cardiac Nerve Activity and Paroxysmal Atrial Tachyarrhythmia in Ambulatory Dogs , 2010, Circulation.

[145]  Dhanunjaya R. Lakkireddy,et al.  Periprocedural Stroke and Management of Major Bleeding Complications in Patients Undergoing Catheter Ablation of Atrial Fibrillation: The Impact of Periprocedural Therapeutic International Normalized Ratio , 2010, Circulation.

[146]  Vadim V Fedorov,et al.  Anatomy and Electrophysiology of the Human AV Node , 2010, Pacing and clinical electrophysiology : PACE.

[147]  D. Benditt,et al.  Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation. , 2010, Heart rhythm.

[148]  J. Le Heuzey,et al.  A Short‐Term, Randomized, Double‐Blind, Parallel‐Group Study to Evaluate the Efficacy and Safety of Dronedarone versus Amiodarone in Patients with Persistent Atrial Fibrillation: The DIONYSOS Study , 2010, Journal of cardiovascular electrophysiology.

[149]  L. La Vecchia,et al.  Efficacy and safety of catheter ablation versus antiarrhythmic drugs for atrial fibrillation: a meta-analysis of randomized trials , 2010, Journal of cardiovascular medicine.

[150]  Stefan Kääb,et al.  Genetics of Atrial Fibrillation: Implications for Future Research Directions and Personalized Medicine , 2010, Circulation. Arrhythmia and electrophysiology.

[151]  D. Packer,et al.  Long-term quality of life after ablation of atrial fibrillation the impact of recurrence, symptom relief, and placebo effect. , 2010, Journal of the American College of Cardiology.

[152]  M. Böhm,et al.  Prevention of Atrial Fibrillation by Renin-Angiotensin System Inhibition , 2010 .

[153]  S. Lotfipour,et al.  Challenging the superiority of amiodarone for rate control in Wolff-Parkinson-White and atrial fibrillation , 2010, Internal and emergency medicine.

[154]  P. Zimetbaum,et al.  Are atrial fibrillation patients receiving warfarin in accordance with stroke risk? , 2010, The American journal of medicine.

[155]  Otto Kamp,et al.  Lenient versus strict rate control in patients with atrial fibrillation. , 2010, The New England journal of medicine.

[156]  Michel Haissaguerre,et al.  Efficacy of catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: impact of age, atrial remodelling, and disease progression. , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[157]  P. Kirchhof,et al.  Predictable and less predictable unwanted cardiac drugs effects: individual pre-disposition and transient precipitating factors. , 2010, Basic & clinical pharmacology & toxicology.

[158]  S. Themistoclakis,et al.  The risk of thromboembolism and need for oral anticoagulation after successful atrial fibrillation ablation. , 2010, Journal of the American College of Cardiology.

[159]  Robby Nieuwlaat,et al.  Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis. , 2010, Journal of the American College of Cardiology.

[160]  Gregory Y H Lip,et al.  Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. , 2010, Chest.

[161]  Burr Hall,et al.  Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. , 2010, JAMA.

[162]  H. Pak,et al.  Safety and Convenience of Continuous Warfarin Strategy During the Periprocedural Period in Patients Who Underwent Catheter Ablation of Atrial Fibrillation , 2009, Journal of cardiovascular electrophysiology.

[163]  D. Tamborero,et al.  Efficacy of circumferential pulmonary vein ablation of atrial fibrillation in endurance athletes , 2009, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[164]  Elia Biganzoli,et al.  Updated Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation , 2005, Circulation. Arrhythmia and electrophysiology.

[165]  Wang He.  Warfarin Prevention of Thromboembolism in Patients With Non-rheumatic Atrial Fibrillation , 2010 .

[166]  R. Vest.  Comparative Efficacy of Dronedarone and Amiodarone for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation , 2010 .

[167]  I. Savelieva,et al.  Primary and secondary prevention of atrial fibrillation with statins and polyunsaturated fatty acids: review of evidence and clinical relevance , 2010, Naunyn-Schmiedeberg's Archives of Pharmacology.

[168]  S. Yusuf,et al.  Dabigatran versus warfarin in patients with atrial fibrillation. , 2009, The New England journal of medicine.

[169]  S. Connolly,et al.  Effect of dronedarone on cardiovascular events in atrial fibrillation. , 2009, The New England journal of medicine.

[170]  Stephan Willems,et al.  Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF'. , 2009, European heart journal.

[171]  Richard A. Kronmal,et al.  N-Terminal Pro-B-Type Natriuretic Peptide Is a Major Predictor of the Development of Atrial Fibrillation: The Cardiovascular Health Study , 2009, Circulation.

[172]  J. Epstein,et al.  Melanocyte‐like cells in the heart and pulmonary veins contribute to atrial arrhythmia triggers , 2009, The Journal of clinical investigation.

[173]  Dongfeng Qi,et al.  The Relationship Between Daily Atrial Tachyarrhythmia Burden From Implantable Device Diagnostics and Stroke Risk: The TRENDS Study , 2009, Circulation. Arrhythmia and electrophysiology.

[174]  G. Wassmer,et al.  Statins for prevention of atrial fibrillation after cardiac surgery: a systematic literature review. , 2009, The Journal of thoracic and cardiovascular surgery.

[175]  S. Narayan,et al.  Five-year outcomes after segmental pulmonary vein isolation for paroxysmal atrial fibrillation. , 2009, The American journal of cardiology.

[176]  C. Gieger,et al.  A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke , 2009, Nature Genetics.

[177]  Jesper Hastrup Svendsen,et al.  Familial Aggregation of Atrial Fibrillation: A Study in Danish Twins , 2009, Circulation. Arrhythmia and electrophysiology.

[178]  Matthew R. Reynolds,et al.  Treatment of Atrial Fibrillation With Antiarrhythmic Drugs or Radiofrequency Ablation: Two Systematic Literature Reviews and Meta-Analyses , 2009, Circulation. Arrhythmia and electrophysiology.

[179]  K. Ellenbogen,et al.  Long-Term Outcomes After Catheter Ablation of Cavo-Tricuspid Isthmus Dependent Atrial Flutter: A Meta-Analysis , 2009, Circulation. Arrhythmia and electrophysiology.

[180]  Eric Boerwinkle,et al.  Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry , 2009, Nature Genetics.

[181]  P. Kirchhof,et al.  Giant T-U waves precede torsades de pointes in long QT syndrome: a systematic electrocardiographic analysis in patients with acquired and congenital QT prolongation. , 2009, Journal of the American College of Cardiology.

[182]  Hung-Fat Tse,et al.  Intravenous diltiazem is superior to intravenous amiodarone or digoxin for achieving ventricular rate control in patients with acute uncomplicated atrial fibrillation* , 2009, Critical care medicine.

[183]  Elsayed Z Soliman,et al.  Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study. , 2009, American heart journal.

[184]  J. Hartikainen,et al.  The Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in Paroxysmal Atrial Fibrillation (MANTRA-PAF) trial: clinical rationale, study design, and implementation. , 2009, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[185]  M. Mack,et al.  Minimally invasive surgical ablation of atrial fibrillation: six-month results. , 2009, The Journal of thoracic and cardiovascular surgery.

[186]  D. Holmes,et al.  Bleeding, blood transfusion, and increased mortality after percutaneous coronary intervention: implications for contemporary practice. , 2009, Journal of the American College of Cardiology.

[187]  Nancy R Cook,et al.  Relation of vigorous exercise to risk of atrial fibrillation. , 2009, The American journal of cardiology.

[188]  Salim Yusuf,et al.  Effect of clopidogrel added to aspirin in patients with atrial fibrillation. , 2009, The New England journal of medicine.

[189]  R. Steinman,et al.  Amiodarone-induced torsade de pointes in a patient with wolff-Parkinson-White syndrome. , 2009, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

[190]  Joshua J. E. Blauer,et al.  Detection and Quantification of Left Atrial Structural Remodeling With Delayed-Enhancement Magnetic Resonance Imaging in Patients With Atrial Fibrillation , 2009, Circulation.

[191]  N. Limdi,et al.  Kidney function influences warfarin responsiveness and hemorrhagic complications. , 2009, Journal of the American Society of Nephrology : JASN.

[192]  W. Baker,et al.  Meta-Analysis to Assess the Quality of Warfarin Control in Atrial Fibrillation Patients in the United States , 2009, Journal of managed care pharmacy : JMCP.

[193]  C. Cannon,et al.  Differential use of warfarin for secondary stroke prevention in patients with various types of atrial fibrillation. , 2009, The American journal of cardiology.

[194]  D. Shah.  ECG manifestations of left atrial flutter , 2009, Current opinion in cardiology.

[195]  G. Breithardt,et al.  The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[196]  D. Wyse,et al.  Pharmacotherapy for rhythm management in elderly patients with atrial fibrillation , 2009, Journal of Interventional Cardiac Electrophysiology.

[197]  N. Cook,et al.  Alcohol consumption and risk of incident atrial fibrillation in women. , 2008, JAMA.

[198]  Albert Hofman,et al.  Cigarette smoking and risk of atrial fibrillation: the Rotterdam Study. , 2008, American heart journal.

[199]  David O. Martin,et al.  Pulmonary-vein isolation for atrial fibrillation in patients with heart failure. , 2008, The New England journal of medicine.

[200]  Jagmeet P. Singh,et al.  Cardiac resynchronization in patients with atrial fibrillation: a meta-analysis of prospective cohort studies. , 2008, Journal of the American College of Cardiology.

[201]  Joshua J. E. Blauer,et al.  New magnetic resonance imaging based method to define extent of left atrial wall injury after the ablation of atrial fibrillation , 2008 .

[202]  S. Ommen,et al.  Substrate and Procedural Predictors of Outcomes After Catheter Ablation for Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy , 2008, Journal of cardiovascular electrophysiology.

[203]  C. Gieger,et al.  Risk variants for atrial fibrillation on chromosome 4q25 associate with ischemic stroke , 2008, Annals of neurology.

[204]  E. Blackstone,et al.  Success of surgical left atrial appendage closure: assessment by transesophageal echocardiography. , 2008, Journal of the American College of Cardiology.

[205]  J. Davy,et al.  Dronedarone for the control of ventricular rate in permanent atrial fibrillation: the Efficacy and safety of dRonedArone for the cOntrol of ventricular rate during atrial fibrillation (ERATO) study. , 2008, American heart journal.

[206]  L. Popescu,et al.  Interstitial Cajal-like cells (ICLC) in myocardial sleeves of human pulmonary veins , 2008, Journal of cellular and molecular medicine.

[207]  A. Camm,et al.  Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure , 2009 .

[208]  J. McMurray,et al.  Increased mortality after dronedarone therapy for severe heart failure. , 2008, The New England journal of medicine.

[209]  M. Monreal,et al.  Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE Registry , 2008, Thrombosis and Haemostasis.

[210]  Tong Liu,et al.  Statin use and development of atrial fibrillation: a systematic review and meta-analysis of randomized clinical trials and observational studies. , 2008, International journal of cardiology.

[211]  Stanley Nattel,et al.  Atrial Remodeling and Atrial Fibrillation: Mechanisms and Implications , 2008, Circulation. Arrhythmia and electrophysiology.

[212]  S. Nattel,et al.  Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. , 2008, Journal of the American College of Cardiology.

[213]  Philippe Pibarot,et al.  Mechanisms, prevention, and treatment of atrial fibrillation after cardiac surgery. , 2008, Journal of the American College of Cardiology.

[214]  Albert L. Waldo,et al.  Inter-relationships of atrial fibrillation and atrial flutter mechanisms and clinical implications. , 2008, Journal of the American College of Cardiology.

[215]  G. Kay,et al.  Proarrhythmic Aspects of Atrial Fibrillation Surgery: Mechanisms of Postoperative Macroreentrant Tachycardias , 2008, Circulation.

[216]  J. Molnar,et al.  Prevention of Atrial Fibrillation by Way of Abrogation of the Renin-Angiotensin System: A Systematic Review and Meta-Analysis , 2008, American journal of therapeutics.

[217]  E. Aliot,et al.  Delayed rhythm control of atrial fibrillation may be a cause of failure to prevent recurrences: reasons for change to active antiarrhythmic treatment at the time of the first detected episode. , 2007, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[218]  D. V. Van Wagoner,et al.  Prednisone Prevents Inducible Atrial Flutter in the Canine Sterile Pericarditis Model , 2007, Journal of cardiovascular electrophysiology.

[219]  A. Raviele,et al.  Antiarrhythmic Effect of Statin Therapy and Atrial Fibrillation A Meta-Analysis of Randomized Controlled Trials. , 2008, Journal of atrial fibrillation.

[220]  Jacky Serveille,et al.  [Ablation of atrial fibrillation]. , 2008, Soins; la revue de reference infirmiere.

[221]  S. Jensen,et al.  A randomized double-blind study of epicardial left atrial cryoablation for permanent atrial fibrillation in patients undergoing mitral valve surgery: the SWEDish Multicentre Atrial Fibrillation study (SWEDMAF). , 2007, European heart journal.

[222]  David O. Martin,et al.  Atrial Fibrillation Ablation in Patients With Therapeutic International Normalized Ratio: Comparison of Strategies of Anticoagulation Management in the Periprocedural Period , 2007, Circulation.

[223]  E. Aliot,et al.  Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. , 2007, The New England journal of medicine.

[224]  M. Frenneaux,et al.  Syncope in hypertrophic cardiomyopathy: mechanisms and consequences for treatment. , 2007, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[225]  G. Lip,et al.  Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial , 2007, The Lancet.

[226]  David O. Martin,et al.  Incidence of Atrial Fibrillation Post‐Cavotricuspid Isthmus Ablation in Patients with Typical Atrial Flutter: Left‐Atrial Size as an Independent Predictor of Atrial Fibrillation Recurrence , 2007, Journal of cardiovascular electrophysiology.

[227]  Eric E. Smith,et al.  Variants conferring risk of atrial fibrillation on chromosome 4q25 , 2007, Nature.

[228]  M. Aguilar,et al.  Oral Anticoagulants Versus Antiplatelet Therapy for Preventing Stroke in Patients With Nonvalvular Atrial Fibrillation and No History of Stroke or Transient Ischemic Attacks , 2008 .

[229]  F. Gaita,et al.  Usefulness and safety of transcatheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy. , 2007, The American journal of cardiology.

[230]  M. Rosenqvist,et al.  Maintenance of sinus rhythm with metoprolol CR initiated before cardioversion and repeated cardioversion of atrial fibrillation: a randomized double-blind placebo-controlled study. , 2007, European heart journal.

[231]  René M. Botnar,et al.  Detection of pulmonary vein and left atrial scar after catheter ablation with three-dimensional navigator-gated delayed enhancement MR imaging: initial experience. , 2007, Radiology.

[232]  N. Varma,et al.  Surface Electrocardiographic Patterns and Electrophysiologic Characteristics of Atrial Flutter Following Modified Radiofrequency MAZE Procedures , 2007, Journal of cardiovascular electrophysiology.

[233]  M. Niemelä,et al.  Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting. , 2007, European heart journal.

[234]  D. Levy,et al.  Pulse pressure and risk of new-onset atrial fibrillation. , 2007, JAMA.

[235]  B. Psaty,et al.  Newly detected atrial fibrillation and compliance with antithrombotic guidelines. , 2007, Archives of internal medicine.

[236]  V. Somers,et al.  Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. , 2007, Journal of the American College of Cardiology.

[237]  D. Lin,et al.  Reversal of Left Ventricular Dysfunction Following Ablation of Atrial Fibrillation , 2007, Journal of cardiovascular electrophysiology.

[238]  J. Cairns,et al.  nonvalvular atrial fibrillation , 2007 .

[239]  E. Mazzaferri.  Thyroid Status, Cardiovascular Risk, and Mortality in Older Adults , 2007 .

[240]  Benjamin J. Epstein,et al.  Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure , 2007 .

[241]  J. Macgregor,et al.  The effects of rate and irregularity on sympathetic nerve activity in human subjects. , 2007, Heart rhythm.

[242]  S. Mouly,et al.  Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation. , 2007, The Cochrane database of systematic reviews.

[243]  J. Dunning,et al.  Guidelines on the prevention and management of de novo atrial fibrillation after cardiac and thoracic surgery. , 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[244]  N. Peters,et al.  Can atrial fibrillation with a coarse electrocardiographic appearance be treated with catheter ablation of the tricuspid valve–inferior vena cava isthmus? Results of a multicentre randomised controlled trial , 2006, Heart.

[245]  E. Heist,et al.  Analysis of the left atrial appendage by magnetic resonance angiography in patients with atrial fibrillation. , 2006, Heart rhythm.

[246]  V. Pasceri,et al.  Randomized Trial of Atorvastatin for Reduction of Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery: Results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) Study , 2006, Circulation.

[247]  C. Negrão,et al.  Selective Atrial Vagal Denervation Guided by Evoked Vagal Reflex to Treat Patients With Paroxysmal Atrial Fibrillation , 2006, Circulation.

[248]  F. Morady,et al.  Risk of Thromboembolic Events After Percutaneous Left Atrial Radiofrequency Ablation of Atrial Fibrillation , 2006, Circulation.

[249]  Catherine Klersy,et al.  Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation. , 2006, Journal of the American College of Cardiology.

[250]  M. Pfeffer,et al.  Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. , 2006, American heart journal.

[251]  M. Pfeffer,et al.  Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial , 2006, The Lancet.

[252]  C. Steinwender,et al.  Effects of a high dose intravenous bolus amiodarone in patients with atrial fibrillation and a rapid ventricular rate. , 2006, International journal of cardiology.

[253]  A. Forster,et al.  Effect of study setting on anticoagulation control: a systematic review and metaregression. , 2006, Chest.

[254]  M. Coceani,et al.  Catheter Ablation of Long‐Lasting Persistent Atrial Fibrillation: Clinical Outcome and Mechanisms of Subsequent Arrhythmias , 2006, Journal of cardiovascular electrophysiology.

[255]  S. Mouly,et al.  Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: a systematic review of randomized controlled trials. , 2006, Archives of internal medicine.

[256]  S. Themistoclakis,et al.  Efficacy of catheter ablation of atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy. , 2006, Heart rhythm.

[257]  M. Rich,et al.  Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF). , 2006, American heart journal.

[258]  F. Morady,et al.  Characteristics of Cavotricuspid Isthmus–Dependent Atrial Flutter After Left Atrial Ablation of Atrial Fibrillation , 2006, Circulation.

[259]  K. Chandrasekaran,et al.  Safety of expedited anticoagulation in patients undergoing transesophageal echocardiographic-guided cardioversion. , 2006, The American journal of medicine.

[260]  Hugh Calkins,et al.  Characterization of radiofrequency ablation lesions with gadolinium-enhanced cardiovascular magnetic resonance imaging. , 2006, Journal of the American College of Cardiology.

[261]  A. Waldo.  Radiofrequency Ablation vs Antiarrhythmic Drugs as First-line Treatment of Symptomatic Atrial Fibrillation: A Randomized Trial , 2006 .

[262]  N. Samani,et al.  Left atrial radiofrequency ablation during mitral valve surgery for continuous atrial fibrillation: a randomized controlled trial. , 2005, JAMA.

[263]  Prashanthan Sanders,et al.  Catheter Ablation of Long‐Lasting Persistent Atrial Fibrillation: Clinical Outcome and Mechanisms of Subsequent Arrhythmias , 2005, Journal of cardiovascular electrophysiology.

[264]  E. Daoud,et al.  Left Ventricular‐Based Cardiac Stimulation Post AV Nodal Ablation Evaluation (The PAVE Study) , 2005, Journal of cardiovascular electrophysiology.

[265]  R. Becker,et al.  Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation. , 2005, Journal of the American College of Cardiology.

[266]  L. Lai,et al.  Left atrial dysfunction in patients with atrial fibrillation after successful rhythm control for > 3 months. , 2005, Chest.

[267]  P. Vestergaard,et al.  Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study. , 2005, The American journal of medicine.

[268]  J. Ramires,et al.  Effectiveness of the Maze Procedure Using Cooled-Tip Radiofrequency Ablation in Patients With Permanent Atrial Fibrillation and Rheumatic Mitral Valve Disease , 2005, Circulation.

[269]  J. Langberg,et al.  Atrial Fibrillation Increases Production of Superoxide by the Left Atrium and Left Atrial Appendage: Role of the NADPH and Xanthine Oxidases , 2005, Circulation.

[270]  E. Lonn,et al.  Left Atrial Appendage Occlusion Study (LAAOS): results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke. , 2005, American heart journal.

[271]  P. Vardas,et al.  Comparative assessment of right, left, and biventricular pacing in patients with permanent atrial fibrillation. , 2005, European heart journal.

[272]  M. Aguilar,et al.  Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks. , 2005, The Cochrane database of systematic reviews.

[273]  Christopher Piorkowski,et al.  Perception of Atrial Fibrillation Before and After Radiofrequency Catheter Ablation: Relevance of Asymptomatic Arrhythmia Recurrence , 2005, Circulation.

[274]  J. Ruskin,et al.  Clinical Subtypes of Lone Atrial Fibrillation , 2005, Pacing and clinical electrophysiology : PACE.

[275]  S. Yusuf,et al.  Clinical ResearchHeart Rhythm DisorderPrevention of Atrial Fibrillation With Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: A Meta-Analysis , 2005 .

[276]  H. I. Çikriklar,et al.  Comparison of the effectiveness of intravenous diltiazem and metoprolol in the management of rapid ventricular rate in atrial fibrillation , 2005, Emergency Medicine Journal.

[277]  D. Reda,et al.  Amiodarone versus sotalol for atrial fibrillation. , 2005, The New England journal of medicine.

[278]  B. Maron,et al.  Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy. , 2005, Journal of the American College of Cardiology.

[279]  A. Amin,et al.  A pharmacologic overview of current and emerging anticoagulants. , 2005, Cleveland Clinic journal of medicine.

[280]  J. McMurray,et al.  Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial. , 2005, Journal of the American College of Cardiology.

[281]  L. Kalra,et al.  Are Cost Benefits of Anticoagulation for Stroke Prevention in Atrial Fibrillation Underestimated? , 2005, Stroke.

[282]  Douglas L Packer,et al.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.

[283]  D. Parish,et al.  Obesity and the risk of new-onset atrial fibrillation. , 2005, JAMA.

[284]  P. Vestergaard,et al.  Work related physical activity and risk of a hospital discharge diagnosis of atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study , 2004, Occupational and Environmental Medicine.

[285]  Prashanthan Sanders,et al.  Catheter ablation for atrial fibrillation in congestive heart failure. , 2004, The New England journal of medicine.

[286]  P. Alboni,et al.  Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket" approach. , 2004, The New England journal of medicine.

[287]  P. Vestergaard,et al.  Hyperthyroidism and risk of atrial fibrillation or flutter: a population-based study. , 2004, Archives of internal medicine.

[288]  B. Gage,et al.  Selecting Patients With Atrial Fibrillation for Anticoagulation: Stroke Risk Stratification in Patients Taking Aspirin , 2004, Circulation.

[289]  P. Vestergaard,et al.  Alcohol and risk of atrial fibrillation or flutter: a cohort study. , 2004, Archives of internal medicine.

[290]  J. Boineau,et al.  Atrial Tachyarrhythmias After the Maze Procedure: Incidence and Prognosis , 2004, Circulation.

[291]  D. Levy,et al.  Lifetime Risk for Development of Atrial Fibrillation: The Framingham Heart Study , 2004, Circulation.

[292]  B. Olshansky,et al.  Heart Failure and Sudden Death in Patients With Tachycardia-Induced Cardiomyopathy and Recurrent Tachycardia , 2004, Circulation.

[293]  P. Koudstaal,et al.  Anticoagulants for Preventing Stroke in Patients With Nonrheumatic Atrial Fibrillation and a History of Stroke or Transient Ischemic Attack , 2004, The Cochrane database of systematic reviews.

[294]  Ralph B D'Agostino,et al.  Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. , 2004, JAMA.

[295]  R. Kalil,et al.  Randomized study of surgery for patients with permanent atrial fibrillation as a result of mitral valve disease. , 2004, The Annals of thoracic surgery.

[296]  O. Ergene,et al.  Efficacy of propafenone for maintaining sinus rhythm in patients with recent onset or persistent atrial fibrillation after conversion: a randomized, placebo-controlled study , 2004, Acta cardiologica.

[297]  J. Mathew,et al.  A multicenter risk index for atrial fibrillation after cardiac surgery. , 2004, JAMA.

[298]  Brian Olshansky,et al.  The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: approaches to control rate in atrial fibrillation. , 2004, Journal of the American College of Cardiology.

[299]  M. Domanski,et al.  Relationships Between Sinus Rhythm, Treatment, and Survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study , 2004, Circulation.

[300]  S. Steinhubl,et al.  Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation. , 2004, American heart journal.

[301]  Daniel Levy,et al.  Plasma natriuretic peptide levels and the risk of cardiovascular events and death. , 2004, The New England journal of medicine.

[302]  N. Smedira,et al.  Effectiveness of atrial fibrillation surgery in patients with hypertrophic cardiomyopathy. , 2004, The American journal of cardiology.

[303]  J. Mounsey,et al.  Antiarrhythmic drug therapy of atrial fibrillation. , 2004, Cardiology clinics.

[304]  L. Tamariz,et al.  Pharmacological rate control of atrial fibrillation. , 2004, Cardiology clinics.

[305]  O. Alfieri,et al.  Pulmonary Vein Denervation Enhances Long-Term Benefit After Circumferential Ablation for Paroxysmal Atrial Fibrillation , 2004, Circulation.

[306]  Otto Kamp,et al.  Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) Study. , 2004, Journal of the American College of Cardiology.

[307]  J. Gurwitz,et al.  Age-Specific Differences in the Use of Thrombolytic Therapy and Hospital Outcomes in Patients with Acute Myocardial Infarction: A Community-Wide Perspective , 2002, Journal of Thrombosis and Thrombolysis.

[308]  P. Batin,et al.  A randomized placebo-controlled trial of pre-treatment and short- or long-term maintenance therapy with amiodarone supporting DC cardioversion for persistent atrial fibrillation. , 2004, European heart journal.

[309]  E. E. van der Wall,et al.  Paroxysmal atrial fibrillation in male endurance athletes. A 9-year follow up. , 2004, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[310]  M. Scanavacca,et al.  Surgical treatment of atrial fibrillation through isolation of the left atrial posterior wall in patients with chronic rheumatic mitral valve disease. A randomized study with control group. , 2004, Arquivos brasileiros de cardiologia.

[311]  Kenneth A. Ellenbogen,et al.  The Ablate and Pace Trial: A Prospective Study of Catheter Ablation of the AV Conduction System and Permanent Pacemaker Implantation for Treatment of Atrial Fibrillation , 2004, Journal of Interventional Cardiac Electrophysiology.

[312]  Bruce M Psaty,et al.  Inflammation as a Risk Factor for Atrial Fibrillation , 2003, Circulation.

[313]  J. Cleland,et al.  Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure? , 2003, Journal of the American College of Cardiology.

[314]  J. Boineau,et al.  The Cox maze III procedure for atrial fibrillation: long-term efficacy in patients undergoing lone versus concomitant procedures. , 2003, The Journal of thoracic and cardiovascular surgery.

[315]  R. Page,et al.  Efficacy and safety of sustained-release propafenone (propafenone SR) for patients with atrial fibrillation. , 2003, The American journal of cardiology.

[316]  J. Bermejo,et al.  Role of left atrial appendage obliteration in stroke reduction in patients with mitral valve prosthesis: a transesophageal echocardiographic study. , 2003, Journal of the American College of Cardiology.

[317]  B. Reichart,et al.  Surgical treatment of permanent atrial fibrillation using microwave energy ablation: a prospective randomized clinical trial. , 2003, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[318]  Liming Zhang,et al.  Cellular electrophysiology of canine pulmonary vein cardiomyocytes: action potential and ionic current properties , 2003, The Journal of physiology.

[319]  U. Ozbek,et al.  Combined radiofrequency modified maze and mitral valve procedure through a port access approach: early and mid-term results. , 2003, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[320]  A. Capucci,et al.  Dronedarone for prevention of atrial fibrillation: a dose-ranging study. , 2003, European heart journal.

[321]  David M Herrington,et al.  C-Reactive Protein, Carotid Intima-Media Thickness, and Incidence of Ischemic Stroke in the Elderly: The Cardiovascular Health Study , 2003, Circulation.

[322]  Douglas L Packer,et al.  Familial atrial fibrillation is a genetically heterogeneous disorder. , 2003, Journal of the American College of Cardiology.

[323]  J. Murabito,et al.  Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality The Framingham Heart Study , 2003, Circulation.

[324]  M. Josephson,et al.  Safety and feasibility of a clinical pathway for the outpatient initiation of antiarrhythmic medications in patients with atrial fibrillation or atrial flutter. , 2003, The American journal of cardiology.

[325]  I. Khan,et al.  Amiodarone for pharmacological cardioversion of recent-onset atrial fibrillation. , 2003, International journal of cardiology.

[326]  M. Bulsara,et al.  The Australian Intervention Randomized Control of Rate in Atrial Fibrillation Trial (AIRCRAFT). , 2003, Journal of the American College of Cardiology.

[327]  G. Guyatt,et al.  Effectiveness of amiodarone for conversion of atrial fibrillation to sinus rhythm: a meta-analysis. , 2003, Archives of internal medicine.

[328]  G. Lamas,et al.  Atrial High Rate Episodes Detected by Pacemaker Diagnostics Predict Death and Stroke: Report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST) , 2003, Circulation.

[329]  W. Maisel,et al.  Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. , 2003, The American journal of cardiology.

[330]  Harlan M Krumholz,et al.  Association of serum digoxin concentration and outcomes in patients with heart failure. , 2003, JAMA.

[331]  N. V. van Hemel,et al.  A randomized study of combining maze surgery for atrial fibrillation with mitral valve surgery. , 2003, The Journal of cardiovascular surgery.

[332]  H. Crijns,et al.  A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. , 2002, The New England journal of medicine.

[333]  James B Seward,et al.  Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women. , 2002, Journal of the American College of Cardiology.

[334]  Simon Stewart,et al.  A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. , 2002, The American journal of medicine.

[335]  C. M. Hart,et al.  Embolic complications of direct current cardioversion of atrial arrhythmias: association with low intensity of anticoagulation at the time of cardioversion. , 2002, Journal of the American College of Cardiology.

[336]  N. Kanuru,et al.  Cardiac resynchronization in patients with congestive heart failure and chronic atrial fibrillation: effect of upgrading to biventricular pacing after chronic right ventricular pacing. , 2002, Journal of the American College of Cardiology.

[337]  J. Brugada,et al.  Long-lasting sport practice and lone atrial fibrillation. , 2002, European heart journal.

[338]  B. Maron,et al.  Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy. , 2002, Journal of the American College of Cardiology.

[339]  Pablo A. Chiale,et al.  Efficacy of Amiodarone for the Termination of Chronic Atrial Fibrillation and Maintenance of Normal Sinus Rhythm: A Prospective, Multicenter, Randomized, Controlled, Double Blind Trial , 2001, Journal of cardiovascular pharmacology and therapeutics.

[340]  B. Maron,et al.  Impact of Atrial Fibrillation on the Clinical Course of Hypertrophic Cardiomyopathy , 2001, Circulation.

[341]  A. Camm,et al.  Initial energy setting, outcome and efficiency in direct current cardioversion of atrial fibrillation and flutter. , 2001, Journal of the American College of Cardiology.

[342]  M. Rich,et al.  Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. , 2001, JAMA.

[343]  M. Leoncini,et al.  Long-term efficacy and safety of propafenone and sotalol for the maintenance of sinus rhythm after conversion of recurrent symptomatic atrial fibrillation. , 2001, The American journal of cardiology.

[344]  M. Chung,et al.  Ascorbate Attenuates Atrial Pacing-Induced Peroxynitrite Formation and Electrical Remodeling and Decreases the Incidence of Postoperative Atrial Fibrillation , 2001, Circulation research.

[345]  K. Müller,et al.  Surgical treatment of atrial fibrillation using radiofrequency ablation , 2009 .

[346]  B. Gersh,et al.  Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation. , 2001, The New England journal of medicine.

[347]  L. Køber,et al.  Efficacy of Dofetilide in the Treatment of Atrial Fibrillation-Flutter in Patients With Reduced Left Ventricular Function: A Danish Investigations of Arrhythmia and Mortality ON Dofetilide (DIAMOND) Substudy , 2001, Circulation.

[348]  W. Manning,et al.  Early cardioversion of atrial fibrillation facilitated by transesophageal echocardiography: short-term safety and impact on maintenance of sinus rhythm at 1 year. , 2001, The American journal of medicine.

[349]  M. Haumer,et al.  Amiodarone versus diltiazem for rate control in critically ill patients with atrial tachyarrhythmias , 2001, Critical care medicine.

[350]  C. Lau,et al.  Comparison Of Digoxin Versus Low‐Dose Amiodarone For Ventricular Rate Control In Patients With Chronic Atrial Fibrillation , 2001, Clinical and experimental pharmacology & physiology.

[351]  D. Singer,et al.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. , 2001, JAMA.

[352]  M. Jensen-Urstad,et al.  factors predicting success rate and recurrence of atrial fibrillation after first electrical cardioversion in patients with persistent atrial fibrillation , 2001, Clinical cardiology.

[353]  I. Khan.  Single oral loading dose of propafenone for pharmacological cardioversion of recent-onset atrial fibrillation. , 2001, Journal of the American College of Cardiology.

[354]  P. Vardas,et al.  Sotalol vs metoprolol for ventricular rate control in patients with chronic atrial fibrillation who have undergone digitalization: a single-blinded crossover study. , 2001, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[355]  A. Laupacis,et al.  Antiplatelet Therapy for Preventing Stroke in Patients With Nonvalvular Atrial Fibrillation and No Previous History of Stroke or Transient Ischemic Attacks , 2005, The Cochrane database of systematic reviews.

[356]  M. Brodsky,et al.  Efficacy and Safety of Oral Dofetilide in Converting to and Maintaining Sinus Rhythm in Patients With Chronic Atrial Fibrillation or Atrial Flutter: The Symptomatic Atrial Fibrillation Investigative Research on Dofetilide (SAFIRE-D) Study , 2000, Circulation.

[357]  N. Boon,et al.  Thyroid disease and the heart , 2000, Heart.

[358]  A. Aggarwal.  Amiodarone to prevent recurrence of atrial fibrillation. , 2000, The New England journal of medicine.

[359]  M. Mansour,et al.  Spatially Distributed Dominant Excitation Frequencies Reveal Hidden Organization in Atrial Fibrillation in the Langendorff‐Perfused Sheep Heart , 2000, Journal of cardiovascular electrophysiology.

[360]  J. Thomas,et al.  Efficacy of anticoagulation in resolving left atrial and left atrial appendage thrombi: A transesophageal echocardiographic study. , 2000, American heart journal.

[361]  J. Jalife,et al.  Temporal Organization of Atrial Activity and Irregular Ventricular Rhythm During Spontaneous Atrial Fibrillation: , 2000, Journal of cardiovascular electrophysiology.

[362]  F. Morady,et al.  A randomized trial comparing heparin initiation 6 h or 24 h after pacemaker or defibrillator implantation. , 2000, Journal of the American College of Cardiology.

[363]  J B Seward,et al.  Clinical profile and outcome of idiopathic restrictive cardiomyopathy. , 2000, Circulation.

[364]  G. Steinbeck,et al.  Catheter ablation of atrial flutter due to amiodarone therapy for paroxysmal atrial fibrillation. , 2000, European heart journal.

[365]  P. Tchou,et al.  Transthoracic cardioversion of atrial fibrillation: comparison of rectilinear biphasic versus damped sine wave monophasic shocks. , 2000, Circulation.

[366]  G. Kay,et al.  Clinical outcomes after ablation and pacing therapy for atrial fibrillation : a meta-analysis. , 2000, Circulation.

[367]  K A Schulman,et al.  Acute myocardial infarction complicated by atrial fibrillation in the elderly: prevalence and outcomes. , 2000, Circulation.

[368]  J Jalife,et al.  Stable microreentrant sources as a mechanism of atrial fibrillation in the isolated sheep heart. , 2000, Circulation.

[369]  Marlene R. Miller,et al.  The evidence regarding the drugs used for ventricular rate control. , 2000, The Journal of family practice.

[370]  O. Benavente,et al.  Antithrombotic Therapy To Prevent Stroke in Patients with Atrial Fibrillation , 1999, Annals of Internal Medicine.

[371]  G F Michaud,et al.  Electrocardiographic differentiation of atrial flutter from atrial fibrillation by physicians. , 1999, Journal of electrocardiology.

[372]  A. Camm,et al.  Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group. , 1999, The New England journal of medicine.

[373]  T. Guarnieri,et al.  Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery: the Amiodarone Reduction in Coronary Heart (ARCH) trial. , 1999, Journal of the American College of Cardiology.

[374]  J. Williams,et al.  Maintenance of sinus rhythm with oral d,l-sotalol therapy in patients with symptomatic atrial fibrillation and/or atrial flutter. d,l-Sotalol Atrial Fibrillation/Flutter Study Group. , 1999, The American journal of cardiology.

[375]  S Nattel,et al.  Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. , 1999, Circulation.

[376]  F. Morady,et al.  Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment. , 1999, The New England journal of medicine.

[377]  M. Ezekowitz,et al.  Initiating and Maintaining Patients on Warfarin Anticoagulation: The Importance of Monitoring , 1999, Journal of cardiovascular pharmacology and therapeutics.

[378]  Bramahn . Singh,et al.  Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens. , 1999, Journal of the American College of Cardiology.

[379]  P. Schweitzer,et al.  Timing of thromboembolic events after electrical cardioversion of atrial fibrillation or flutter: a retrospective analysis. , 1998, The American journal of cardiology.

[380]  B. Winters,et al.  &ggr;‐Adrenergic Blockade Accelerates Conversion of Postoperative Supraventricular Tachyarrhythmias , 1998, Anesthesiology.

[381]  M. Noble,et al.  Myocardial contractility is not constant during spontaneous atrial fibrillation in patients. , 1998, Circulation.

[382]  P A Wolf,et al.  Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. , 1998, The American journal of cardiology.

[383]  M. Brignole,et al.  Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation: a randomized, controlled study. , 1998, Circulation.

[384]  J Clémenty,et al.  Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. , 1998, The New England journal of medicine.

[385]  K. Ellenbogen,et al.  Intravenous amiodarone for acute heart rate control in the critically ill patient with atrial tachyarrhythmias. , 1998, The American journal of cardiology.

[386]  F. Morady,et al.  Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery , 1997 .

[387]  B. Phillips,et al.  Comparison of Intravenous Diltiazem and Verapamil for the Acute Treatment of Atrial Fibrillation and Atrial Flutter , 1997, Pharmacotherapy.

[388]  M. Brignole,et al.  Assessment of atrioventricular junction ablation and DDDR mode-switching pacemaker versus pharmacological treatment in patients with severely symptomatic paroxysmal atrial fibrillation: a randomized controlled study. , 1997, Circulation.

[389]  G. Kay,et al.  Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. , 1997, Journal of the American College of Cardiology.

[390]  Thomas E. Moritz,et al.  Atrial fibrillation after cardiac surgery: a major morbid event? , 1997, Annals of surgery.

[391]  M. Russo,et al.  Histological substrate of atrial biopsies in patients with lone atrial fibrillation. , 1997, Circulation.

[392]  R. Califf,et al.  Atrial fibrillation in the setting of acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries. , 1997, Journal of the American College of Cardiology.

[393]  M. Kinoshita,et al.  Incidence of ischemic strokes in hypertrophic cardiomyopathy is markedly increased if complicated by atrial fibrillation. , 1997, Japanese circulation journal.

[394]  P. Danias,et al.  Risk for Clinical Thromboembolism Associated with Conversion to Sinus Rhythm in Patients with Atrial Fibrillation Lasting Less Than 48 Hours , 1997, Annals of Internal Medicine.

[395]  L. Jordaens,et al.  Conversion of atrial fibrillation to sinus rhythm and rate control by digoxin in comparison to placebo. , 1997, European heart journal.

[396]  J Clémenty,et al.  A focal source of atrial fibrillation treated by discrete radiofrequency ablation. , 1997, Circulation.

[397]  J. Brugada,et al.  Ventricular Fibrillation and Sudden Death After Radiofrequency Catheter Ablation of the Atrioventricular Junction , 1997, Pacing and clinical electrophysiology : PACE.

[398]  B. Iung,et al.  AREVA: multicenter randomized comparison of low-dose versus standard-dose anticoagulation in patients with mechanical prosthetic heart valves. , 1996, Circulation.

[399]  K. Ellenbogen,et al.  Efficacy of ibutilide for termination of atrial fibrillation and flutter. , 1996, The American journal of cardiology.

[400]  Mark A. Wood,et al.  Efficacy and Safety of Repeated Intravenous Doses of Ibutilide for Rapid Conversion of Atrial Flutter or Fibrillation , 1996 .

[401]  M. Santini,et al.  Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study. , 1996, Journal of the American College of Cardiology.

[402]  L. Cohn,et al.  Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources. , 1996, Circulation.

[403]  W. Browner,et al.  Atrial fibrillation following coronary artery bypass graft surgery: predictors, outcomes, and resource utilization. MultiCenter Study of Perioperative Ischemia Research Group. , 1996, JAMA.

[404]  F. Oehme.  Goodman and Gilman 's: The pharmacological basis of therapeutics , 1996 .

[405]  R B D'Agostino,et al.  Secular trends in the prevalence of atrial fibrillation: The Framingham Study. , 1996, American heart journal.

[406]  J. Odell,et al.  Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. , 1996, The Annals of thoracic surgery.

[407]  B. Maron,et al.  Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population. , 1995, Journal of the American College of Cardiology.

[408]  M. Allessie,et al.  Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. , 1995, Circulation.

[409]  P. Oettgen,et al.  Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: final results of a prospective 4.5-year study. , 1995, Journal of the American College of Cardiology.

[410]  F A Mathewson,et al.  The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. , 1995, The American journal of medicine.

[411]  M. Chang,et al.  Acute treatment of recent-onset atrial fibrillation and flutter with a tailored dosing regimen of intravenous amiodarone. A randomized, digoxin-controlled study. , 1995, European heart journal.

[412]  R. Cebul,et al.  Limitations of transesophageal echocardiography in the risk assessment of patients before nonanticoagulated cardioversion from atrial fibrillation and flutter: an analysis of pooled trials. , 1995, American heart journal.

[413]  K. Koh,et al.  Efficacy and safety of digoxin alone and in combination with low-dose diltiazem or betaxolol to control ventricular rate in chronic atrial fibrillation. , 1995, The American journal of cardiology.

[414]  M. Burch,et al.  Hypertrophic cardiomyopathy. , 1994, Archives of disease in childhood.

[415]  R. D'Agostino,et al.  Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. , 1994, The New England journal of medicine.

[416]  G. Feld,et al.  Control of rapid ventricular response by radiofrequency catheter modification of the atrioventricular node in patients with medically refractory atrial fibrillation. , 1994, Circulation.

[417]  M. Niebauer,et al.  Radiofrequency catheter modification of atrioventricular conduction to control the ventricular rate during atrial fibrillation. , 1994, The New England journal of medicine.

[418]  J Haaksma,et al.  Analysis of vagal effects on ventricular rhythm in patients with atrial fibrillation. , 1994, Clinical science.

[419]  G. Klein,et al.  Risk of Sudden Arrhythmic Death in the Wolff‐Parkinson‐White Syndrome: Current Perspectives , 1994, Pacing and clinical electrophysiology : PACE.

[420]  A. Zbrozek,et al.  Effectiveness and costs of digoxin treatment for atrial fibrillation and flutter. , 1993, The American journal of cardiology.

[421]  H. Crijns,et al.  Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion of chronic atrial fibrillation unassociated with cardiac valve disease. , 1993, The American journal of cardiology.

[422]  J. Wodniecki,et al.  Effect of sotalol on arrhythmias and exercise tolerance in patients with hypertrophic cardiomyopathy. , 1993, Cardiology.

[423]  S. Lévy,et al.  Predictors of In‐Hospital Mortality After DC Catheter Ablation of Atrioventricular Junction: Results of a Prospective, International, Multicenter Study , 1991, Circulation.

[424]  D M Mirvis,et al.  A placebo-controlled trial of continuous intravenous diltiazem infusion for 24-hour heart rate control during atrial fibrillation and atrial flutter: a multicenter study. , 1991, Journal of the American College of Cardiology.

[425]  P. Wolf,et al.  Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. , 1991, Stroke.

[426]  S. Lévy,et al.  [Oral propranolol in Wolff-Parkinson-White syndrome. Electrophysiological data]. , 1991, Archives des maladies du coeur et des vaisseaux.

[427]  H L Greene,et al.  Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. , 1991, The New England journal of medicine.

[428]  P. Coumel,et al.  Ventricular fibrillation in the Wolff-Parkinson-White syndrome. , 1991, European heart journal.

[429]  L. Rydén,et al.  Ventricular rate control and exercise performance in chronic atrial fibrillation: effects of diltiazem and verapamil. , 1990, Journal of the American College of Cardiology.

[430]  I. V. Van Gelder,et al.  Efficacy and safety of flecainide acetate in the maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation or atrial flutter. , 1989, The American journal of cardiology.

[431]  E. Michelson,et al.  Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter. , 1989, The American journal of cardiology.

[432]  J. McMurray,et al.  Effects of atenolol, verapamil, and xamoterol on heart rate and exercise tolerance in digitalised patients with chronic atrial fibrillation. , 1989, Journal of cardiovascular pharmacology.

[433]  L. E. Peterson,et al.  Disopyramide in the maintenance of sinus rhythm after electroconversion of atrial fibrillation. A placebo-controlled one-year follow-up study. , 1988, European heart journal.

[434]  P. Petersen,et al.  Stroke in thyrotoxicosis with atrial fibrillation. , 1988, Stroke.

[435]  P. Wolf,et al.  Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. , 1987, Archives of internal medicine.

[436]  J. Steinberg,et al.  Efficacy of oral diltiazem to control ventricular response in chronic atrial fibrillation at rest and during exercise. , 1987, Journal of the American College of Cardiology.

[437]  J Abrams,et al.  Efficacy and safety of esmolol vs propranolol in the treatment of supraventricular tachyarrhythmias: a multicenter double-blind clinical trial. , 1985, American heart journal.

[438]  R. Gianelly,et al.  Fatal ventricular fibrillation following verapamil in Wolff-Parkinson-White syndrome with atrial fibrillation. , 1985, Annals of emergency medicine.

[439]  T. Agner,et al.  A reevaluation of atrial fibrillation in thyrotoxicosis. , 1984, Danish medical bulletin.

[440]  W. Dassen,et al.  A comparison of the electrophysiologic effects of intravenous and oral amiodarone in the same patient. , 1984, Circulation.

[441]  G. Klein,et al.  Acceleration of the Ventricular Response During Atrial Fibrillation in the Wolff‐Parkinson‐White Syndrome After Verapamil , 1982, Circulation.

[442]  M. Ehrenfeld,et al.  Arterial embolism in thyrotoxicosis with atrial fibrillation. , 1981, Archives of internal medicine.

[443]  J. Stockigt,et al.  Atrial fibrillation and arterial embolism in hyperthyroidism. , 1981, Australian and New Zealand journal of medicine.

[444]  M. Akhtar,et al.  Effect of Lidocaine on Atrioventricular Response Via the Accessory Pathway in Patients with Wolff‐Parkinson‐White Syndrome , 1981, Circulation.

[445]  N. Georgiev.  [Multifocal atrial tachycardia]. , 2020, Vutreshni bolesti.

[446]  N. Burki.  Chronic airway obstruction. , 1980, The Journal of family practice.

[447]  A L Waldo,et al.  Characterization of Atrial Flutter: Studies in Man After Open Heart Surgery Using Fixed Atrial Electrodes , 1979, Circulation.

[448]  P. Thompson,et al.  EMBOLISM IN THYROTOXIC ATRIAL FIBRILLATION , 1979, The Medical journal of Australia.

[449]  B. Maron,et al.  Prevalence of arrhythmias during 24-hour electrocardiographic monitoring and exercise testing in patients with obstructive and nonobstructive hypertrophic cardiomyopathy. , 1979, Circulation.

[450]  R Slama,et al.  [The atrial arrhythmia syndrome of vagal origin]. , 1978, Archives des maladies du coeur et des vaisseaux.

[451]  L. Schamroth.  Immediate effects of intravenous verapamil on atrial fibrillation. , 1971, Cardiovascular research.

[452]  Williams Mh,et al.  OBSTRUCTIVE PULMONARY DISEASE , 1964 .

[453]  J A ABILDSKOV,et al.  Atrial fibrillation as a self-sustaining arrhythmia independent of focal discharge. , 1959, American heart journal.

[454]  D. Scherf,et al.  Experimental studies on auricular flutter and auricular fibrillation. , 1948, American heart journal.

[455]  Rimm,et al.  Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. , 2001, The New England journal of medicine.

[456]  Wolters Kluwer,et al.  Hrs/ehra/ecas Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design: a Report of the Heart Rhythm Society (hrs) Task Force , 2022 .